ARTICLE | Clinical News
Epstein-Barr virus (EBV) vaccine: Began Phase II trial
October 30, 2000 8:00 AM UTC
Aviron (AVIR), Mountain View, Calif. Product: Epstein-Barr virus (EBV) vaccine Business: Infectious diseases Therapeutic category: Immune stimulation Target: Immune cells Description: EBV surface anti...